These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 989013)

  • 21. Interaction of warfarin with human serum albumin. A stoichiometric description.
    Larsen FG; Larsen CG; Jakobsen P; Brodersen R
    Mol Pharmacol; 1985 Feb; 27(2):263-70. PubMed ID: 3969070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of protein concentration on the binding of drugs to human serum albumin--I. Sulfadiazine, salicylate and phenylbutazone.
    Boobis SW; Chignell CF
    Biochem Pharmacol; 1979 Mar; 28(6):751-6. PubMed ID: 454474
    [No Abstract]   [Full Text] [Related]  

  • 23. High-throughput solution-based medicinal library screening against human serum albumin.
    Flarakos J; Morand KL; Vouros P
    Anal Chem; 2005 Mar; 77(5):1345-53. PubMed ID: 15732917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.
    O'Reilly RA; Goulart DA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):691-4. PubMed ID: 7299692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
    García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
    Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of site-specific binding and co-binding of ligands to human serum albumin using 19F NMR.
    Jenkins BG; Lauffer RB
    Mol Pharmacol; 1990 Jan; 37(1):111-8. PubMed ID: 2300044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
    Wosilait WD; Ryan MP; Byington KH
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
    Plum A; Müller LK; Jansen JA
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermodynamics of fatty acid anion displacement of warfarin and phenylbutazone from human albumin.
    Rippie EG
    Biochem Pharmacol; 1976 May; 25(10):1215-6. PubMed ID: 938544
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of glycosylation on the drug binding of human serum albumin.
    Koizumi K; Ikeda C; Ito M; Suzuki J; Kinoshita T; Yasukawa K; Hanai T
    Biomed Chromatogr; 1998; 12(4):203-10. PubMed ID: 9667024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
    Mais RF; Keresztes-Nagy S; Zaroslinski JF; Oester YT
    J Pharm Sci; 1974 Sep; 63(9):1423-7. PubMed ID: 4427265
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenytoin binding to human albumin.
    Lecomte M; Zini R; d'Athis P; Tillement JP
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):23-8. PubMed ID: 467465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma.
    Nilsen OG; Storstein L; Jacobsen S
    Biochem Pharmacol; 1977 Feb; 26(3):229-35. PubMed ID: 843392
    [No Abstract]   [Full Text] [Related]  

  • 35. Semi-micro-scale frontal gel chromatography of interacting systems of a protein and small molecules: binding of warfarin, tryptophan, or FMN to albumin, and of o-nitrophenol to catechol 2,3-dioxygenase.
    Honjo M; Ishida T; Horiike K
    J Biochem; 1997 Aug; 122(2):258-63. PubMed ID: 9378700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone.
    O'Reilly RA
    Ann N Y Acad Sci; 1973 Nov; 226():293-308. PubMed ID: 4520398
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of competitive displacement agents to resolve albumin binding problems observed during the development of a radioimmunoassay for ICI 215001.
    Ballard P; Malone MD; Law B
    J Pharm Biomed Anal; 1994 Jan; 12(1):47-52. PubMed ID: 7909237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of acute renal failure on the protein binding of drugs in animals and in man.
    Belpaire FM; Bogaert MG; Mussche MM
    Eur J Clin Pharmacol; 1977; 11(1):27-32. PubMed ID: 832654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting drug binding in plasma of elderly patients.
    Wallace S; Whiting B
    Br J Clin Pharmacol; 1976 Apr; 3(2):327-30. PubMed ID: 973967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid method for the estimation of drug-albumin affinity constants in human plasma.
    Solomon HM; Thomas GB
    Clin Pharmacol Ther; 1971; 12(3):445-8. PubMed ID: 5567799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.